05/15/2025
9:27 AM | HCW Biologics (Filer)
| Form 424B4 | |
05/14/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
05/13/2025
3:18 PM | HCW Biologics (Filer)
| Form S-1/A | |
05/09/2025
4:28 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:29 PM | Flowers Lee (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:30 PM | Byam Rebecca (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:31 PM | GARRETT SCOTT T (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | HCW Biologics (Issuer)
Wong Hing C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:33 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
12:55 PM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/28/2025
8:17 AM | HCW Biologics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for HCWB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
7:45 AM | HCW Biologics (Filer)
| Form DEFA14A | |
04/28/2025
7:50 AM | HCW Biologics (Filer)
| Form ARS | |
04/22/2025
4:15 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
11:15 PM | HCW Biologics (Filer)
| Form EFFECT | |
04/16/2025
3:26 PM | HCW Biologics (Filer)
| Form 424B3 | |
04/07/2025
5:06 AM | HCW Biologics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/01/2025
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
2:45 PM | HCW Biologics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
4:00 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:29 PM | HCW Biologics (Filer)
| Form DEF 14A | |
02/11/2025
3:54 PM | HCW Biologics (Filer)
| Form PRE 14A | |
02/07/2025
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
6:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
7:30 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | HCW Biologics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/22/2024
3:53 PM | HCW Biologics (Subject)
Wong Hing C (Filed by)
| Form SC 13D/A | |
11/22/2024
3:45 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
11:54 AM | HCW Biologics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
11/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:25 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K/A | |
08/14/2024
3:45 PM | HCW Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
3:40 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:35 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
6:00 AM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:30 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon just did WHAT!? (Ad) As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC.
Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever.
But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs…
Paving the way for Elon Musk's secret master plan. Click here to see how to claim your stake before they launch to avoid missing out. |
06/17/2024
3:56 PM | HCW Biologics (Issuer)
Winer Gary M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:57 PM | Greene Rick S. (Reporting)
HCW Biologics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:33 PM | HCW Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:36 PM | HCW Biologics (Filer)
| Form ARS/A | |
